Hb Clinico-Madrid [alpha90(FG2)Lys-->Arg]: a new hemoglobin mutation in the alpha2-globin gene

Importance of the 3'UTR region in globin synthesis: identification of two novel HBA1 mutations causing α-Thalassemia.

Annals of hematology·2025

New Measurements of the Deuteron-to-Proton F_{2} Structure-Function Ratio.

Physical review letters·2025

New insights into the integrative effects of resistance training at moderate altitude on systemic inflammation.

European journal of applied physiology·2025

Strength and muscle mass development after a resistance-training period at terrestrial and normobaric intermittent hypoxia.

Pflugers Archiv : European journal of physiology·2024

Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial.

ESMO open·2022

Ruling out Color Transparency in Quasielastic ^{12}C(e,e^{'}p) up to Q^{2} of 14.2 (GeV/c)^{2}.

Physical review letters·2021

Mapping the Management-to-Cure Transition in Thalassemia Research: Semantic Topic Modeling of 17,651 Publications Across Three Decades.

Hemoglobin·2026

Uncovering the True Genotype: Unusually Severe Sickle Cell Disease in a Child with an Initial HbSC Diagnosis.

Hemoglobin·2026

Ocular Complications Among Patients with Beta-Thalassemia Major and Intermedia Patients: A Comparative Study from Pakistan.

Hemoglobin·2026

Psychometric Performance of the Adult Sickle Cell Quality-of-Life Measurement Information System (ASCQ-Me) in Jamaicans with Sickle Cell Disease.

Hemoglobin·2026

Co-Heredity of (-α)20.5 Deletion and IVS I-1 G > A (HBB: C.92 + 1 G > A) Mutations in a Pediatric Patient: A Cause of Moderate Anemia Phenotype?

Hemoglobin·2026

Hemoglobin E Associated with Hemoglobin Constant Spring: Diagnostic Challenges in Heterozygous and Homozygous States.

Hemoglobin·2026

Clinical Efficacy of High-Frequency Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression and the Predictive Role of Baseline Triglyceride Levels: A Randomized Sham-Controlled Trial.

Clinical EEG and neuroscience·2026

Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.

Journal of medicinal chemistry·2026

Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.

Journal of medicinal chemistry·2026

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Haematologica·2026

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Haematologica·2026

Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.

Frontiers in aging·2026

Related Experiment Videos

Hb Clinico-Madrid [alpha90(FG2)Lys-->Arg]: a new hemoglobin mutation in the alpha2-globin gene

Related Concept Videos

Importance of the 3'UTR region in globin synthesis: identification of two novel HBA1 mutations causing α-Thalassemia.

New Measurements of the Deuteron-to-Proton F_{2} Structure-Function Ratio.

New insights into the integrative effects of resistance training at moderate altitude on systemic inflammation.

Strength and muscle mass development after a resistance-training period at terrestrial and normobaric intermittent hypoxia.

Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial.

Ruling out Color Transparency in Quasielastic ^{12}C(e,e^{'}p) up to Q^{2} of 14.2 (GeV/c)^{2}.

Mapping the Management-to-Cure Transition in Thalassemia Research: Semantic Topic Modeling of 17,651 Publications Across Three Decades.

Uncovering the True Genotype: Unusually Severe Sickle Cell Disease in a Child with an Initial HbSC Diagnosis.

Ocular Complications Among Patients with Beta-Thalassemia Major and Intermedia Patients: A Comparative Study from Pakistan.

Psychometric Performance of the Adult Sickle Cell Quality-of-Life Measurement Information System (ASCQ-Me) in Jamaicans with Sickle Cell Disease.

Co-Heredity of (-α)20.5 Deletion and IVS I-1 G > A (HBB: C.92 + 1 G > A) Mutations in a Pediatric Patient: A Cause of Moderate Anemia Phenotype?

Hemoglobin E Associated with Hemoglobin Constant Spring: Diagnostic Challenges in Heterozygous and Homozygous States.

Clinical Efficacy of High-Frequency Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression and the Predictive Role of Baseline Triglyceride Levels: A Randomized Sham-Controlled Trial.

Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.

Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.

Related Experiment Videos

Hb Clinico-Madrid [alpha90(FG2)Lys-->Arg]: a new hemoglobin mutation in the alpha2-globin gene

Related Concept Videos

Related Articles